EMD525797

EMD525797 · Merck KGaA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EMD525797, covering 2016-05-13 to 2016-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of EMD525797 in Solid Tumor Patients in Japan [Phase 1]